Kemptamide

CAS No. 89315-28-6

Kemptamide( ——— )

Catalog No. M42205 CAS No. 89315-28-6

Kemptamide, a 13 amino acid fragment with a sequence corresponding to residues 11-23 of gizzard light chain. Kemptamide is a peptide substrate of myosin light-chain kinase (MLCK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Kemptamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Kemptamide, a 13 amino acid fragment with a sequence corresponding to residues 11-23 of gizzard light chain. Kemptamide is a peptide substrate of myosin light-chain kinase (MLCK).
  • Description
    Kemptamide is a synthetic peptide with 13-residue.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    89315-28-6
  • Formula Weight
    1517.76
  • Molecular Formula
    C65H112N24018
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. C Foster, et al. Tryptic digestion of myosin light chain kinase produces an inactive fragment that is activated on continued digestion. Arch Biochem Biophys. 1986 Dec;251(2):616-23.?
molnova catalog
related products
  • Ganoderic acid beta

    Ganoderic acid beta is a constituent from the fruiting body of Ganoderma lucidum (Fr.) Karst.

  • Testosterone undecan...

    Testosterone undecanoate is a metabolite of Testosterone, which is a promising androgen for male hormonal contraception.

  • Lasmiditan

    Lasmiditan, also known as COL-144 and LY573144, is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist (K1=2.21 μM) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study.